Axogen, Inc. — Director's Dealing 2020

Dec 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2020-12-15

Reporting Person: DeVinney Erick Wayne (VP, Clinical&Translational Sc)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-15	Common Stock	M	15000	$4.81	Acquired	66056	Direct
2020-12-15	Common Stock	F	4373	$16.50	Disposed	61683	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-15	Employee Stock Option (right to buy)	$4.81	M	15000	Disposed	2021-01-02	Common Stock (15000)	Direct

Footnotes

F1: This reflects the number of shares that became vested as of January 2, 2018.

F2: Represents the number of shares swapped to cover the exercise price of the options exercised via an attestation method stock swap in accordance with Rule 16b-3.